Collegium Pharmaceutical Inc (COLL)

[floblu14]

10 Growth Stocks Under $20 in Billionaire Ken Fisher’s Portfolio

Mon, December 6, 2021, 1:42 PM

10. Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Number of Hedge Fund Holders: 13

Price as of December 5, 2021: $17.61 per share

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) is a pharmaceutical company that focuses on developing medicines for pain management. Latest data shows that Fisher Asset Management owned 20,349 shares of the company at the end of the third quarter of 2021 worth $402,000.

HC Wainwright analyst Oren Livnat has a Buy rating on Collegium Pharmaceutical, Inc. (NASDAQ:COLL) stock with a price target of $26. In a recent investor note, the analyst appreciated the potential of pipeline drugs of the firm.

Among the hedge funds being tracked by Insider Monkey, New York-based firm Rubric Capital Management is a leading shareholder in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) with 2.6 million shares worth more than $51 million.

At the end of the third quarter of 2021, 13 hedge funds in the database of Insider Monkey held stakes worth $144 million in Collegium Pharmaceutical, Inc. (NASDAQ:COLL), down from 16 in the preceding quarter worth $209 million.

Just like Apple Inc. (NASDAQ:AAPL), Microsoft Corporation (NASDAQ:MSFT), Amazon.com, Inc. (NASDAQ:AMZN), and Alphabet Inc. (NASDAQ:GOOG), Collegium Pharmaceutical, Inc. (NASDAQ:COLL) is one of the stocks on the radar of growth investors.

https://finance.yahoo.com/news/10-growth-stocks-under-20-184250597.html